Chris advises on a wide variety of corporate law issues affecting early to late-stage technology and life sciences companies and those who invest in them. He is recognised as a “Recommended Individual” for Venture Capital in the Legal 500 UK 2023 & 2024.
With a significant investor-side practice, Chris has extensive experience advising market leading investors including Kinnevik, VNV, VEF, Amadeus, Coatue, Paypal, Updata, Lightrock, Sony Innovation Fund and Salesforce Ventures with a focus on UK, pan-European and US centred transactions along with a growing practice in emerging markets.
Chris has represented a wide variety of companies at all stages of the growth lifecycle, ranging from early-stage startups to unicorn companies. Chris has a particular focus on intellectual property rich sectors including life sciences, fintech, SaaS and artificial intelligence.
Chris regularly works on complex cross-border transactions (based upon both BVCA and NVCA style documents) and is familiar with a wide variety of transaction structures including tranched financings and ratchets. In addition to equity financing rounds, Chris advises clients on other corporate transactions including bridge financings, secondary transactions, venture debt, cross-border flip transactions and group reorganisations.
As part of a market leading team, Chris works with his colleagues to provide the full breadth of legal services to technology and life science companies including commercial and customer agreements, intellectual property and employment arrangements.
Prior to joining Orrick, Chris trained and worked at a major international law firm where he advised on several large M&A transactions as well as a number of private equity and venture capital investments.